Benjamin Schrijver

Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4+ T Cells With Skewing Toward a Treg- and Th2-Dominated Phenotype

Kim van der Weerd, Willem A. Dik, Benjamin Schrijver et al. · Diabetes · 2012 · 173 citations · Full text

Peripheral Blood Cd4+, T-regulatory Cell, Immunology +24

Imatinib Mesylate and AMN107 Inhibit PDGF-Signaling in Orbital Fibroblasts: A Potential Treatment for Graves’ Ophthalmopathy

L. van Steensel, Dion Paridaens, Benjamin Schrijver et al. · Investigative Ophthalmology & Visual Science · 2009 · 73 citations

The JAK1/JAK2‐ inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release

Maud A.W. Hermans, Benjamin Schrijver, Conny C.P.A. van Holten‐Neelen et al. · Clinical & Experimental Allergy · 2018 · 60 citations · Full text

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy

Kornvalee Meesilpavikkai, Willem A. Dik, Benjamin Schrijver et al. · Arthritis & Rheumatology · 2019 · 57 citations · Full text

Chilblains Associated, Immunology, Cardiovascular Pharmacology +25

A germline STAT6 gain-of-function variant is associated with early-onset allergies

Narissara Suratannon, Chupong Ittiwut, Willem A. Dik et al. · Journal of Allergy and Clinical Immunology · 2022 · 53 citations

Asthma, Allergy, Allergy Medicine +10